NEUROVASCULAR CONFLICT

This adverse event was reported 16 times

NEUROVASCULAR CONFLICT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CROMOLYN SODIUM 2 0.0005
1 TENAPANOR HYDROCHLORIDE 1 0.0003
2 BEVACIZUMAB-AWWB 1 0.0002
3 TEPROTUMUMAB 1 0.0002
4 CANAKINUMAB 1 0.0001
5 BOTULINUM TOXIN TYPE A 1 0.0001
6 CARBAMAZEPINE 4 0.0001
7 LEUCOVORIN CALCIUM 1 0.0001
8 SUMATRIPTAN SUCCINATE 1 0.0000
9 OMALIZUMAB 3 0.0000
See all drugs enriched for association with NEUROVASCULAR CONFLICT